Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager, Csaba P. Kövesdy, Robyn G. Langham, et al.
Nephrology Dialysis Transplantation (2019) Vol. 34, Iss. 11, pp. 1803-1805
Open Access | Times Cited: 359

Showing 1-25 of 359 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4374
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 383
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Alberto Ortíz, Mario Cozzolino, Danilo Fliser, et al.
Nephrology Dialysis Transplantation (2020) Vol. 36, Iss. 1, pp. 87-94
Open Access | Times Cited: 340
Chronic kidney disease and the global public health agenda: an international consensus
Anna Francis, Meera N. Harhay, Albert Ong, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 7, pp. 473-485
Open Access | Times Cited: 269
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update
Stefanos Roumeliotis, Francesca Mallamaci, Carmine Zoccali
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2359-2359
Open Access | Times Cited: 199
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
Jonatan Barrera‐Chimal, Ixchel Lima‐Posada, George L. Bakris, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 1, pp. 56-70
Closed Access | Times Cited: 158
Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments
Xin Sheng, Yuting Guan, Ziyuan Ma, et al.
Nature Genetics (2021) Vol. 53, Iss. 9, pp. 1322-1333
Open Access | Times Cited: 128
Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis
Tomohito Doke, Amin Abedini, Daniel L. Aldridge, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 947-959
Closed Access | Times Cited: 82
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, et al.
The Lancet (2023) Vol. 403, Iss. 10424, pp. 379-390
Open Access | Times Cited: 70
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
Hiddo J.L. Heerspink, Arihiro Kiyosue, David C. Wheeler, et al.
The Lancet (2023) Vol. 402, Iss. 10416, pp. 2004-2017
Open Access | Times Cited: 68
The impact of population ageing on the burden of chronic kidney disease
Nicholas C. Chesnaye, Alberto Ortíz, Carmine Zoccali, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 569-585
Closed Access | Times Cited: 36
Physiologic Homeostasis after Pig-to-Human Kidney Xenotransplantation
Eric Judd, Vineeta Kumar, Paige M. Porrett, et al.
Kidney International (2024)
Open Access | Times Cited: 24
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
Na Wang, Chun Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3086-3086
Open Access | Times Cited: 23
Roles of Nrf2 in Protecting the Kidney from Oxidative Damage
Masahiro Nezu, Norio Suzuki
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2951-2951
Open Access | Times Cited: 128
Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney
Raymond Vanholder, Lieven Annemans, Aminu K. Bello, et al.
Clinical Kidney Journal (2021) Vol. 14, Iss. 7, pp. 1719-1730
Open Access | Times Cited: 99
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study
George L. Bakris, Pablo E. Pérgola, Belkis Delgado, et al.
Hypertension (2021) Vol. 78, Iss. 1, pp. 74-81
Open Access | Times Cited: 94
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India
Narayan Prasad, Mansi Bhatt, Sanjay Kumar Agarwal, et al.
Kidney International Reports (2020) Vol. 5, Iss. 9, pp. 1545-1550
Open Access | Times Cited: 77
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic
Lilio Hu, Angelodaniele Napoletano, Michele Provenzano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12223-12223
Open Access | Times Cited: 67
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 5, pp. 429.e1-429.e104
Closed Access | Times Cited: 47
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA
Patrick B. Mark, Pantelis Sarafidis, Robert Ekart, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 11, pp. 2444-2455
Open Access | Times Cited: 40
Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis
Eneyew Talie Fenta, Habitu Birhan Eshetu, Natnael Kebede, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases
Qi Feng, Yang Yang, Kaidi Ren, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3726-3743
Open Access | Times Cited: 36
Advances in the management of chronic kidney disease
Teresa K. Chen, Melanie P. Hoenig, Dorothea Nitsch, et al.
BMJ (2023), pp. e074216-e074216
Open Access | Times Cited: 29
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
Pantelis Sarafidis, Fotini Iatridi, Charles J. Ferro, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1885-1907
Open Access | Times Cited: 26
Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study
Navdeep Tangri, Emily Peach, Stefan Franzén, et al.
Advances in Therapy (2023) Vol. 40, Iss. 6, pp. 2869-2885
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top